1392 – Treated Diabetes Mellitus In Institutionalized Patients With Schizophrenia

Abstract

Introduction

Patients with schizophrenia have higher cardiovascular morbidity and mortality compared to the general population. They also have a high levels of cardiovascular mortality risk factors: hypertension, smoking, hyperglycemia, physical inactivity, obesity and dyslipidemia, However, the presence of type 2 diabetes mellitus in institutionalized patients with schizophrenia has not been well studied.

Objectives

To establish an association between type 2 diabetes mellitus and schizophrenia in patients living in residential homes.

Aims

To confirm a high prevalence of diabetes mellitus treatment in these patients.

Methods

Four residential institutions for patients with schizophrenia were chosen for the study. There were a total of 145 patients with schizophrenia. The first had 48 patients, males 30 and females 18, the second had 42 patients; 29 males 13 females, the third had 27 patients; 13 males and 14 females and the fourth had 28 patients; 15 males and 13 females. Computerized pharmacy print outs and records from the institutions and our office charts were reviewed.

Results

Of the 145 institutionalized schizophrenia patients, there were 87 males (60%) and 58 females (40%). The average age was 55.76 years. 39(27%) of 145 patients were on treatment for DM; 106(73%) had no diabetes mellitus; 18 (21%) of 87 males had DM and 69 (79%) had no DM; 23 (40%) of 58 females had DM and 35(60%) had no DM.

Conclusion

Type II diabetes mellitus is extremely common (27%) in institutionalized patients with schizophrenia. Due to close medical monitoring, awareness and treatment is one hundred percent.